Status:
RECRUITING
A-eyedrops on Ocular Alignment and Binocular Vision
Lead Sponsor:
Eye & ENT Hospital of Fudan University
Conditions:
Exotropia
Exophoria
Eligibility:
All Genders
5-14 years
Phase:
NA
Brief Summary
Atropine is a non-selective muscarinic acetylcholine (M) receptor antagonist that paralyzes the ciliary muscle, dilates the pupil, and reduces the power of accommodation. Current studies have confirme...
Detailed Description
The prevalence of myopia in the world has exceeded 25% and is increasing year by year. Asia, especially China, is an area with high incidence of myopia. It is reported that the prevalence of myopia in...
Eligibility Criteria
No eligibility criteria provided.
Key Trial Info
Start Date :
March 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2027
Estimated Enrollment :
339 Patients enrolled
Trial Details
Trial ID
NCT05379855
Start Date
March 2 2024
End Date
February 1 2027
Last Update
February 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eye and ENT Hospital, Fudan University
Shanghai, China